Your browser doesn't support javascript.
loading
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis.
Rosar, Florian; Hügle, Martin J; Ries, Martin; Bartholomä, Mark; Maus, Stephan; Fries, Peter; Khreish, Fadi; Ezziddin, Samer.
Affiliation
  • Rosar F; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany - florian.rosar@uks.eu.
  • Hügle MJ; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
  • Ries M; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
  • Bartholomä M; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
  • Maus S; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
  • Fries P; Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg, Germany.
  • Khreish F; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
  • Ezziddin S; Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany.
Q J Nucl Med Mol Imaging ; 66(3): 280-289, 2022 Sep.
Article in En | MEDLINE | ID: mdl-31992688
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Q J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Q J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article